Navigation Links
Biopure Announces 2007 Third Quarter Financial Results
Date:8/23/2007

CAMBRIDGE, Mass., Aug. 23 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) today announced its financial results for the third fiscal quarter ended July 31, 2007. For the quarter, the company reported a net loss of $6.4 million, or $0.08 per common share, compared with a net loss of $6.6 million, or $0.16 per common share, for the corresponding period in 2006. Class A common shares outstanding on July 31, 2007 and 2006 were 77,960,126 and 41,789,370, respectively.

Revenues

Total revenues for the third quarter of 2007 were $550,000, including $470,000 from sales of the company's veterinary product Oxyglobin(R) and $58,000 from sales of Hemopure(R) in South Africa. Total revenues for the same period in 2006 were $396,000, including $312,000 from Oxyglobin sales and $1,000 from sales of Hemopure(R). The increase in Hemopure sales reflects the company's marketing efforts and increasing use of the product. Oxyglobin revenues increased during the third fiscal quarter of 2007 compared to 2006 due to a higher average selling price for product sold in the U.S.

Cost of revenues was $3.1 million for the third quarter of fiscal 2007, compared to $2.9 million for the same period in 2006. Cost of revenues includes costs of both Oxyglobin and Hemopure. The increase is mainly due to higher salaries expense and plant costs.

Expenses

Research and development expenses were $1.6 million for the third quarter of fiscal 2007 compared to $1.8 million during the same period in 2006. Expenses during the third fiscal quarter of 2006 include costs related to the marketing authorization application the company submitted to the United Kingdom regulatory authority in 2006, for which there are no comparable
'/>"/>

SOURCE Biopure Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... upcoming investor conferences. On Tuesday, December 2, ... Annual Piper Jaffray Healthcare Conference.  D. Keith Grossman ... update on the company beginning at 11:30 a.m., Eastern ...
(Date:11/26/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ) ... Executive Officer and President, will participate in the 26 ... New York Palace Hotel in New York ... Eastern Time (ET). To access the live ... to the  Investor Relations  section of the company,s web ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... to Receive Treatment Using Gated... -- BELLINZONA, Switzerland, Aug. 31 ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
... TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ -- ... ... var shortURL = ""; ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
Cached Medicine Technology:Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 2Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 3Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 4Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 5Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 6Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 7Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems 8ScinoPharm to Invest in Tanvex Biologics 2ScinoPharm to Invest in Tanvex Biologics 3ScinoPharm to Invest in Tanvex Biologics 4ScinoPharm to Invest in Tanvex Biologics 5ScinoPharm to Invest in Tanvex Biologics 6
(Date:11/27/2014)... (PRWEB) November 27, 2014 This ... on Global Insulin industry. For an overview analysis, ... classification, application, industry chain structure, industry overview, policy ... global Insulin industry covers information on policy, ... product cost structure and much more. ...
(Date:11/27/2014)... GA (PRWEB) November 27, 2014 "The uglier, ... whole month of December is full of laughter as we ... Wilson won by making a sweater from scratch. " It ... Christmas tree, and if that weren't ridiculous enough, the Christmas ... top. , For those interested in participating this year, ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VeloReality Inc. ... six new Real Life Videos (RLVs) of world-famous velo courses ... Trainer, as well as other popular indoor velo trainers. Two ... available worldwide before the end of November -- in ... the total number of rides in the VeloReality collection to ...
(Date:11/26/2014)... 2014 Healthpointe is proud to provide ... , and it will be led by a renowned ... field of Occupational Medicine and utilizes the latest medical ... delivers quality care for employers and their employees, and ... , As an Occupational Medicine physician, Dr. ...
(Date:11/26/2014)... Day is traditionally the day following Christmas Day, when ... "Christmas box", from their bosses or employers. (Source from ... Day, some people may worry about the boxing day ... it has recently announced its “ Tbdress Boxing Day ... customers. Then people can buy cheap pants, dresses, shoes ...
Breaking Medicine News(10 mins):Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 3Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2
... new robotic surgery technique appears promising for the removal ... report in the December issue of Archives of OtolaryngologyHead ... Typically, surgeons trying to remove tonsils of patients with ... area, according to background information in the article. If ...
... Erline Perkins McGriff Professor and dean of the College of ... College board of,trustees., A 1976 graduate of Skidmore, she ... holds fellow status in the New York Academy of Medicine.,Fulmer ... Gerontological,Society of America, and also the first nurse to be ...
... New Series "Celebrity Rehab with Dr. ... ..., Maybe Baby" and "Scott Baio is 46 ... and Pregnant" Kick Off The New ... ... 2008 with a full,slate of new premieres and returning series. For the first time VH1 ...
... dietician, certified personal trainer, marathoner, and wellness enthusiast will design individualized ... better, longer, healthier and younger ... ... be, better nutrition for active,lifestyles available exclusively at Target stores, announces ...
... 17 Diagnostic Health Corporation,(DHC) today announced that ... its home office operations to 22 Inverness Center ... imaging company created,by HealthSouth,s sale of its diagnostic ... most of DHC,s 1,000 employees work in its ...
... - Aspreva Pharmaceuticals,Corporation (NASDAQ: ASPV ; TSX: ... approved the proposed acquisition of,Aspreva by Galenica Group ... price of US$26.00 per share in cash. At ... transaction was approved,by over 99% of the votes ...
Cached Medicine News:Health News:Robotic device appears useful for surgical removal of cancer involving the tonsils 2Health News:Terry Thomas Fulmer, Dean of NYU's College of Nursing, Elected to Skidmore College Board 2Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 2Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 3Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 4Health News:be(R) is Making Health Simple With Complimentary, Expert Online Diet, Nutrition and Exercise Advice 2Health News:Diagnostic Health Corporation Announces New Home Office Location 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 3Health News:Aspreva obtains shareholder approval for acquisition by Galenica 4
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: